Cargando…

Artificial intelligence in cancer target identification and drug discovery

Artificial intelligence is an advanced method to identify novel anticancer targets and discover novel drugs from biology networks because the networks can effectively preserve and quantify the interaction between components of cell systems underlying human diseases such as cancer. Here, we review an...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Yujie, Lai, Xin, Pan, Yi, Zheng, Huiru, Vera, Julio, Liu, Suran, Deng, Senyi, Zhang, Le
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090746/
https://www.ncbi.nlm.nih.gov/pubmed/35538061
http://dx.doi.org/10.1038/s41392-022-00994-0
_version_ 1784704792674697216
author You, Yujie
Lai, Xin
Pan, Yi
Zheng, Huiru
Vera, Julio
Liu, Suran
Deng, Senyi
Zhang, Le
author_facet You, Yujie
Lai, Xin
Pan, Yi
Zheng, Huiru
Vera, Julio
Liu, Suran
Deng, Senyi
Zhang, Le
author_sort You, Yujie
collection PubMed
description Artificial intelligence is an advanced method to identify novel anticancer targets and discover novel drugs from biology networks because the networks can effectively preserve and quantify the interaction between components of cell systems underlying human diseases such as cancer. Here, we review and discuss how to employ artificial intelligence approaches to identify novel anticancer targets and discover drugs. First, we describe the scope of artificial intelligence biology analysis for novel anticancer target investigations. Second, we review and discuss the basic principles and theory of commonly used network-based and machine learning-based artificial intelligence algorithms. Finally, we showcase the applications of artificial intelligence approaches in cancer target identification and drug discovery. Taken together, the artificial intelligence models have provided us with a quantitative framework to study the relationship between network characteristics and cancer, thereby leading to the identification of potential anticancer targets and the discovery of novel drug candidates.
format Online
Article
Text
id pubmed-9090746
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-90907462022-05-12 Artificial intelligence in cancer target identification and drug discovery You, Yujie Lai, Xin Pan, Yi Zheng, Huiru Vera, Julio Liu, Suran Deng, Senyi Zhang, Le Signal Transduct Target Ther Review Article Artificial intelligence is an advanced method to identify novel anticancer targets and discover novel drugs from biology networks because the networks can effectively preserve and quantify the interaction between components of cell systems underlying human diseases such as cancer. Here, we review and discuss how to employ artificial intelligence approaches to identify novel anticancer targets and discover drugs. First, we describe the scope of artificial intelligence biology analysis for novel anticancer target investigations. Second, we review and discuss the basic principles and theory of commonly used network-based and machine learning-based artificial intelligence algorithms. Finally, we showcase the applications of artificial intelligence approaches in cancer target identification and drug discovery. Taken together, the artificial intelligence models have provided us with a quantitative framework to study the relationship between network characteristics and cancer, thereby leading to the identification of potential anticancer targets and the discovery of novel drug candidates. Nature Publishing Group UK 2022-05-10 /pmc/articles/PMC9090746/ /pubmed/35538061 http://dx.doi.org/10.1038/s41392-022-00994-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review Article
You, Yujie
Lai, Xin
Pan, Yi
Zheng, Huiru
Vera, Julio
Liu, Suran
Deng, Senyi
Zhang, Le
Artificial intelligence in cancer target identification and drug discovery
title Artificial intelligence in cancer target identification and drug discovery
title_full Artificial intelligence in cancer target identification and drug discovery
title_fullStr Artificial intelligence in cancer target identification and drug discovery
title_full_unstemmed Artificial intelligence in cancer target identification and drug discovery
title_short Artificial intelligence in cancer target identification and drug discovery
title_sort artificial intelligence in cancer target identification and drug discovery
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090746/
https://www.ncbi.nlm.nih.gov/pubmed/35538061
http://dx.doi.org/10.1038/s41392-022-00994-0
work_keys_str_mv AT youyujie artificialintelligenceincancertargetidentificationanddrugdiscovery
AT laixin artificialintelligenceincancertargetidentificationanddrugdiscovery
AT panyi artificialintelligenceincancertargetidentificationanddrugdiscovery
AT zhenghuiru artificialintelligenceincancertargetidentificationanddrugdiscovery
AT verajulio artificialintelligenceincancertargetidentificationanddrugdiscovery
AT liusuran artificialintelligenceincancertargetidentificationanddrugdiscovery
AT dengsenyi artificialintelligenceincancertargetidentificationanddrugdiscovery
AT zhangle artificialintelligenceincancertargetidentificationanddrugdiscovery